Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres
作者
Georgia J. B. McCaughan,Anvita Verma,Silvia Ling,Orly Lavee,John J. Moore,Adam J Bryant